TCL Archive Most of NCI’s $60 Million Increase In FY95 will fund Mandatory Raise In Prevention October 14, 1994
TCL Archive Advisors Reaffirm Survival As Standard For full FDA Approval Of Cancer Drugs June 16, 1999
TCL Archive CMS Allows Medicare Payment for Eloxatin, But Says Review of New Agents Likely May 23, 2003
